Indemnity issue to be settled to bring the two US vaccines through COVAX
Sohini Das |
Last Updated at July 7, 2021 23:17 IST
The global Covid vaccine collaboration COVAX says all participants in the facility must have signed the indemnity agreements with the manufacturers in question to receive doses through COVAX.
Before the Moderna and Pfizer messenger ribonucleic acid (or mRNA) vaccines come to India via this route, the legalities around the indemnity clause will have to be settled.
India is expecting 3-4 million doses of Covid vaccines from US majors Moderna and Pfizer soon, claimed Reuters. The international agency said around 3-4 million shots are expected in India through the COVAX facility in August.
COVAX, led by the Gavi vaccine alliance and the World Health Organization, is likely to ship US-made vaccine doses to India as early as this month.
Senior government officials, too, confirmed that procuring vaccine doses through COVAX is an option being actively considered. “Bringing Pfizer and Moderna vaccines through COVAX is one of the routes under consideration,” reiterated an official.
All doses delivered through COVAX are covered by its no-fault compensation programme.
A spokesperson for Gavi told Business Standard, “All facility participants must have signed the indemnity agreements with the manufacturers to receive doses through COVAX — this will also be true for doses received via bilateral deals.”
The facility is helping facilitate the process of getting these agreements in place for lower-income economies, as required. “All doses delivered through COVAX to advance market commitment-eligible economies, donated or procured, are covered by the COVAX no-fault compensation scheme,” the spokesperson added.
Pfizer and Moderna had sought indemnity from legal liabilities for adverse events after vaccination. India has been discussing the issue with the two vaccine makers.
The Indian government is reviewing the legal provisions related to vaccine donations from global suppliers. Moderna vaccines have, however, already reached Pakistan and Bangladesh.
US President Joe Biden had announced earlier that the US would share 80 million doses of its vaccines with the world. Apart from COVAX, the government last month cleared the way for importing Covid vaccines approved by international regulators, without bridging clinical studies. The vaccines will be made available through a tie-up with Mumbai-headquartered Cipla.
Cipla is supporting Moderna with regulatory approval for importing the vaccine to be donated to India, a company spokesperson had said. “At this stage, there is no definitive agreement on commercial supplies,” the spokesperson added. There are no updates on this, Cipla said on Wednesday.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.